Gene therapy approaches for lysosomal storage disorders, a good model for the treatment of mendelian diseases

被引：18

作者：

Tomanin, Rosella

Zanetti, Alessandra

Zaccariotto, Eva

D'Avanzo, Francesca

Bellettato, Cinzia M.

Scarpa, Maurizio ^{[1
]}

机构：

[1] Univ Padua, Dept Pediat, Gene Therapy Lab, I-35128 Padua, Italy

来源：

ACTA PAEDIATRICA | 2012年 / 101卷 / 07期

关键词：

Gene therapy; Lysosomal storage disorders; Mendelian diseases; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; NEURONAL CEROID-LIPOFUSCINOSIS; ACID ALPHA-GLUCOSIDASE; LONG-TERM EXPRESSION; METACHROMATIC LEUKODYSTROPHY; IN-VIVO; MOUSE MODEL; TRANSGENE EXPRESSION; BETA-GLUCURONIDASE;

D O I：

10.1111/j.1651-2227.2012.02674.x

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

This review describes the different gene therapy technologies applied to approach lysosomal storage disorders, monogenic conditions, with known genetic and biochemical defects, for many of which animal models are available. Both viral and nonviral procedures are described, underlying the specific needs that the treatment of genetic disorders requires. Conclusions: Lysosomal storage disorders represent a good model of study of gene therapeutic procedures that are, or could be, relevant to the treatment of several other mendelian diseases.

引用

页码：692 / 701

页数：10

共 64 条

[1] Nonviral Gene Delivery: Principle, Limitations, and Recent Progress
Al-Dosari, Mohammed S.
Gao, Xiang
[J]. AAPS JOURNAL, 2009, 11 (04): : 671 - 681
[2] Systemic Correction of Storage Disease in MPS I NOD/SCID Mice Using the Sleeping Beauty Transposon System
Aronovich, Elena L.
Bell, Jason B.
Khan, Shaukat A.
Belur, Lalitha R.
Gunther, Roland
Koniar, Brenda
Schachern, Patricia A.
Parker, Josh B.
Carlson, Cathy S.
Whitley, Chester B.
McIvor, R. Scott
Gupta, Pankaj
Hackett, Perry B.
[J]. MOLECULAR THERAPY, 2009, 17 (07) : 1136 - 1144
[3] AAV-Mediated Gene Delivery in Adult GM1-Gangliosidosis Mice Corrects Lysosomal Storage in CNS and Improves Survival
Baek, Rena C.
Broekman, Marike L. D.
Leroy, Stanley G.
Tierney, Laryssa A.
Sandberg, Michael A.
d'Azzo, Alessandra
Seyfried, Thomas N.
Sena-Esteves, Miguel
[J]. PLOS ONE, 2010, 5 (10):
[4] Lysosomal disorders: From storage to cellular damage
Ballabio, Andrea
Gieselmann, Volkmar
[J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2009, 1793 (04): : 684 - 696
[5] Therapy for Lysosomal Storage Disorders
Beck, Michael
[J]. IUBMB LIFE, 2010, 62 (01) : 33 - 40
[6] Lysosomal storage diseases and the blood-brain barrier
Begley, David J.
Pontikis, Charles C.
Scarpa, Maurizio
[J]. CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (16) : 1566 - 1580
[7] Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells
Biffi, A
De Palma, M
Quattrini, A
Del Carro, U
Amadio, S
Visigalli, I
Sessa, M
Fasano, S
Brambilla, R
Marchesini, S
Bordignon, C
Naldini, L
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (08) : 1118 - 1129
[8] Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits mice
Biffi, Alessandra
Capotondo, Alessia
Fasano, Stefania
del Carro, Ubaldo
Marchesini, Sergio
Azuma, Hisaya
Malaguti, Maria Chiara
Arnadio, Stefano
Brambilla, Riccardo
Grompe, Markus
Bordignon, Claudio
Quattrini, Angelo
Naldini, Luigi
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (11) : 3070 - 3082
[9] Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors
Brooks, AI
Stein, CS
Hughes, SM
Heth, J
McCray, PM
Sauter, SL
Johnston, JC
Cory-Slechta, DA
Federoff, HJ
Davidson, BL
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (09) : 6216 - 6221
[10] Long-term expression of β-glucuronidase by genetically modified human neural progenitor cells grafted into the mouse central nervous system
Buchet, D
Serguera, C
Zennou, W
Charneau, P
Mallet, J
[J]. MOLECULAR AND CELLULAR NEUROSCIENCE, 2002, 19 (03) : 389 - 401

← 1 2 3 4 5 6 7 →